Enhanced IL-12p40 production in LPS-stimulated macrophages by inhibiting JNK activation by artemisinin

Archives of Pharmacal Research

Volumn 35, Issue 11, 2012, Pages 1961-1968

  Cho, Young Chang ^a   Lee, Sung Ho ^a   Lee, Mina ^a   Kim, Hyun Jung ^b   Oak, Min Ho ^b   Lee, Ik Soo ^a   Kang, Bok Yun ^a  

^a Chonnam National University   (South Korea)

^b Mokpo National University   (South Korea)

Author keywords

Anti microbial; Antitumor; Artemisinin; IL 12; JNK; Macrophage

Indexed keywords

ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; ARTEMISININ; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12P40; JANUS KINASE; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PREGNANCY SPECIFIC BETA1 GLYCOPROTEIN; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANTIMICROBIAL ACTIVITY; ARTICLE; CYTOKINE PRODUCTION; DNA BINDING; HELPER CELL; MACROPHAGE; NONHUMAN; PROTEIN PHOSPHORYLATION; RAT;

EID: 84874442640     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-012-1113-8     Document Type: Article

References (48)

1. Atkins, M. B.; Robertson, M. J.; Gordon, M.; Lotze, M. T.; Decoste, M.; Dubois, J. S.; Ritz, J.; Sandler, A. B.; Edington, H. D.; Garzone, P. D.; Mier, J. W.; Canning, C. M.; Battiato, L.; Tahara, H.; and Sherman, M. L.; Phase I evaluation of intravenous recombinant human interleukin 12 in patients with advanced malignancies. Clin. Cancer. Res.; 3, 409-417 (1997).
2. Braun, M. C. and Kelsall, B. L.; Regulation of interleukin-12 production by G-protein-coupled receptors. Microbes Infect.; 3, 99-107 (2001).
3. Brunda, M. J.; Luistro, L.; Warrier, R. R.; Wright, R. B.; Hubbard, B. R.; Murphy, M.; Wolf, S. F.; and Gately, M. K.; Antitumor and antimetastatic activity of interleukin 12 a gainst murine tumors. J. Exp. Med.; 178, 1223-1230 (1993).
4. Chen, H. H.; Zhou, H. J.; Wu, G. D.; and Lou, X. E.; Inhibitory effects of artesunate on angiogenesis and on expressions of vascular endothelial growth factor and VEGF receptor KDR/flk-1. Pharmacology, 71, 1-9 (2004).
5. Colombo, M. P. and Trinchieri, G.; Interleukin-12 in anti-tumor immunity and immunotherapy. Cytokine Growth Factor Rev.; 13, 155-168 (2002).
6. Cooper, A. M.; Kipnis, A.; Turner, J.; Magram, J.; Ferrante, J.; and Orme, I. M.; Mice lacking bioactive IL-12 can generate protective, antigen-specific cellular responses to mycobacterial infection only if the IL-12 p40 subunit is present. J. Immunol.; 168, 1322-1327 (2002).
7. D'andrea, A.; Rengaraju, M.; Valiante, N. M.; Chehimi, J.; Kubin, M.; Aste, M.; Chan, S. H.; Kobayashi, M.; Young, D.; Nickbarg, E.; Chizzonite, R.; Wolf, S. F.; and Trinchieri G.; Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells. J. Exp. Med.; 176, 1387-1398 (1992).
8. Decken, K.; Kohler, G.; Palmer-Lehmann, K.; Wunderlin, A.; Mattner, F.; Magram, J.; Gately, M. K.; and Alber, G.; Interleukin-12 is essential for a protective Th1 response in mice infected with Cryptococcus neoformans. Infect. Immun.; 66, 4994-5000 (1998).
9. Efferth, T.; Marschall, M.; Wang, X.; Huong, S. M.; Hauber, I.; Olbrich, A.; Kronschnabl, M.; Stamminger, T.; and Huang, E. S.; Antiviral activity of artesunate towards wild-type, recombinant, and ganciclovir-resistant human cytomegaloviruses. J. Mol. Med.; 80, 233-242 (2002).
10. Elkins, K. L.; Cooper, A.; Colombini, S. M.; Cowley, S. C.; and Kieffer, T. L.; In vivo clearance of an intracellular bacterium, Francisella tularensis LVS, is dependent on the p40 subunit of interleukin-12 (IL-12) but not on IL-12 p70. Infect. Immun.; 70, 1936-1948 (2002).
11. Fieschi, C.; Bosticardo, M.; De Beaucoudrey, L.; Boisson-Dupuis, S.; Feinberg, J.; Santos, O. F.; Bustamante, J.; Levy, J.; Candotti, F.; and Casanova, J. L.; A novel form of complete IL-12/IL-23 receptor beta1 deficiency with cell surfaceexpressed nonfunctional receptors. Blood, 104, 2095-2101 (2004).
12. Fieschi, C.; Dupuis, S.; Catherinot, E.; Feinberg, J.; Bustamante, J.; Breiman, A.; Altare, F.; Baretto, R.; Le Deist, F.; Kayal, S.; Koch, H.; Richter, D.; Brezina, M.; Aksu, G.; Wood, P.; Al-Jumaah, S.; Raspall, M.; Da Silva Duarte, A. J.; Tuerlinckx, D.; Virelizier, J. L.; Fischer, A.; Enright, A.; Bernhoft, J.; Cleary, A. M.; Vermylen, C.; Rodriguez-Gallego, C.; Davies, G.; Blutters-Sawatzki, R.; Siegrist, C. A.; Ehlayel, M. S.; Novelli, V.; Haas, W. H.; Levy, J.; Freihorst, J.; Al-Hajjar, S.; Nadal, D.; De Moraes Vasconcelos, D.; Jeppsson, O.; Kutukculer, N.; Frecerova, K.; Caragol, I.; Lammas, D.; Kumararatne, D. S.; Abel, L.; and Casanova, J. L.; Low penetrance, broad resistance, and favorable outcome of interleukin 12 receptor beta1 deficiency: medical and immunological implications. J. Exp. Med.; 197, 527-535 (2003).
13. Gubler, U.; Chua, A. O.; Schoenhaut, D. S.; Dwyer, C. M.; Mccomas, W.; Motyka, R.; Nabavi, N.; Wolitzky, A. G.; Quinn, P. M.; Familletti, P. C.; and Gately, M. K.; Coexpression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor. Proc. Natl. Acad. Sci. U.S.A.; 88, 4143-4147 (1991).
14. Jones-Brando, L.; D'angelo, J.; Posner, G. H.; and Yolken, R.; In vitro inhibition of Toxoplasma gondii by four new derivatives of artemisinin. Antimicrob. Agents Chemother.; 50, 4206-4208 (2006).
15. Kang, Y. J.; Chen, J.; Otsuka, M.; Mols, J.; Ren, S.; Wang, Y.; and Han, J.; Macrophage deletion of p38alpha partially impairs lipopolysaccharide-induced cellular activation. J. Immunol.; 180, 5075-5082 (2008).
16. La Sala, A.; He, J.; Laricchia-Robbio, L.; Gorini, S.; Iwasaki, A.; Braun, M.; Yap, G. S.; Sher, A.; Ozato, K.; and Kelsall, B.; Cholera toxin inhibits IL-12 production and CD8alpha+ dendritic cell differentiation by cAMP-mediated inhibition of IRF8 function. J. Exp. Med.; 206, 1227-1235 (2009).
17. Lehmann, J.; Bellmann, S.; Werner, C.; Schroder, R.; Schutze, N.; and Alber, G.; IL-12p40-dependent agonistic effects on the development of protective innate and adaptive immunity against Salmonella enteritidis. J. Immunol.; 167, 5304-5315 (2001).
18. Li, Y.; Shan, F.; Wu, J. M.; Wu, G. S.; Ding, J.; Xiao, D.; Yang, W. Y.; Atassi, G.; Leonce, S.; Caignard, D. H.; and Renard, P.; Novel antitumor artemisinin derivatives targeting G1 phase of the cell cycle. Bioorg. Med. Chem. Lett.; 11, 5-8 (2001).
19. Lu, H. T.; Yang, D. D.; Wysk, M.; Gatti, E.; Mellman, I.; Davis, R. J.; and Flavell, R. A.; Defective IL-12 production in mitogen-activated protein (MAP) kinase kinase 3 (Mkk3)-deficient mice. EMBO J.; 18, 1845-1857 (1999).
20. Ma, X.; Chow, J. M.; Gri, G.; Carra, G.; Gerosa, F.; Wolf, S. F.; Dzialo, R.; and Trinchieri, G.; The interleukin 12 p40 gene promoter is primed by interferon gamma in monocytic cells. J. Exp. Med.; 183, 147-157 (1996).
21. Magram, J.; Connaughton, S. E.; Warrier, R. R.; Carvajal, D. M.; Wu, C. Y.; Ferrante, J.; Stewart, C.; Sarmiento, U.; Faherty, D. A.; and Gately, M. K.; IL-12-deficient mice are defective in IFN gamma production and type 1 cytokine responses. Immunity, 4, 471-481 (1996).
22. Merali, S. and Meshnick, S. R.; Susceptibility of Pneumocystis carinii to artemisinin in vitro. Antimicrob. Agents Chemother.; 35, 1225-1227 (1991).
23. Mercer, A. E.; Maggs, J. L.; Sun, X. M.; Cohen, G. M.; Chadwick, J.; O'neill, P. M.; and Park, B. K.; Evidence for the involvement of carbon-centered radicals in the induction of apoptotic cell death by artemisinin compounds. J. Biol. Chem.; 282, 9372-9382 (2007).
24. Moore, J. C.; Lai, H.; Li, J. R.; Ren, R. L.; Mcdougall, J. A.; Singh, N. P.; and Chou, C. K.; Oral administration of dihydroartemisinin and ferrous sulfate retarded implanted fibrosarcoma growth in the rat. Cancer Lett.; 98, 83-87 (1995).
25. Murphy, T. L.; Cleveland, M. G.; Kulesza, P.; Magram, J.; and Murphy, K. M.; Regulation of interleukin 12 p40 expression through an NF-kappa B half-site. Mol. Cell. Biol.; 15, 5258-5267 (1995).
26. Nakahara, T.; Uchi, H.; Urabe, K.; Chen, Q.; Furue, M.; and Moroi, Y.; Role of c-Jun N-terminal kinase on lipopolysaccharide induced maturation of human monocyte-derived dendritic cells. Int. Immunol.; 16, 1701-1709 (2004).
27. Pifer, R.; Benson, A.; Sturge, C. R.; and Yarovinsky, F.; UNC93B1 is essential for TLR11 activation and IL-12-dependent host resistance to Toxoplasma gondii. J. Biol. Chem.; 286, 3307-3314 (2011).
28. Plevy, S. E.; Gemberling, J. H.; Hsu, S.; Dorner, A. J.; and Smale, S. T.; Multiple control elements mediate activation of the murine and human interleukin 12 p40 promoters: evidence of functional synergy between C/EBP and Rel proteins. Mol. Cell. Biol.; 17, 4572-4588 (1997).
29. Robertson, M. J.; Cameron, C.; Atkins, M. B.; Gordon, M. S.; Lotze, M. T.; Sherman, M. L.; and Ritz, J.; Immunological effects of interleukin 12 administered by bolus intravenous injection to patients with cancer. Clin. Cancer Res.; 5, 9-16 (1999).
30. Romero, M. R.; Efferth, T.; Serrano, M. A.; Castano, B.; Macias, R. I.; Briz, O.; and Marin, J. J.; Effect of artemisinin/ artesunate as inhibitors of hepatitis B virus production in an "in vitro" replicative system. Antiviral Res.; 68, 75-83 (2005).
31. Salmon, R. A.; Guo, X.; Teh, H. S.; and Schrader, J. W.; The p38 mitogen-activated protein kinases can have opposing roles in the antigen-dependent or endotoxin-stimulated production of IL-12 and IFN-gamma. Eur. J. Immunol.; 31, 3218-3227 (2001).
32. Sanjabi, S.; Hoffmann, A.; Liou, H. C.; Baltimore, D.; and Smale, S. T.; Selective requirement for c-Rel during IL-12 P40 gene induction in macrophages. Proc. Natl. Acad. Sci. U.S.A.; 97, 12705-12710 (2000).
33. Schoenhaut, D. S.; Chua, A. O.; Wolitzky, A. G.; Quinn, P. M.; Dwyer, C. M.; Mccomas, W.; Familletti, P. C.; Gately, M. K.; and Gubler, U.; Cloning and expression of murine IL-12. J. Immunol.; 148, 3433-3440 (1992).
34. Seder, R. A.; Kelsall, B. L.; and Jankovic, D.; Differential roles for IL-12 in the maintenance of immune responses in infectious versus autoimmune disease. J. Immunol.; 157, 2745-2748 (1996).
35. Shimokawa, N.; Nishiyama, C.; Hirota, T.; Tamari, M.; Hara, M.; Ikeda, S.; Okumura, K.; and Ogawa, H.; Functional analysis of a polymorphism in the promoter region of the IL-12/23p40 gene. Clin. Exp. Allergy, 39, 228-235 (2009).
36. Sieburth, D.; Jabs, E. W.; Warrington, J. A.; Li, X.; Lasota, J.; Laforgia, S.; Kelleher, K.; Huebner, K.; Wasmuth, J. J.; and Wolf, S. F.; Assignment of genes encoding a unique cytokine (IL12) composed of two unrelated subunits to chromosomes 3 and 5. Genomics, 14, 59-62 (1992).
37. Trinchieri, G.; Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol.; 13, 251-276 (1995).
38. Utsugi, M.; Dobashi, K.; Ishizuka, T.; Endou, K.; Hamuro, J.; Murata, Y.; Nakazawa, T.; and Mori, M.; c-Jun N-terminal kinase negatively regulates lipopolysaccharide-induced IL-12 production in human macrophages: role of mitogenactivated protein kinase in glutathione redox regulation of IL-12 production. J. Immunol.; 171, 628-635 (2003).
39. Utzinger, J.; Xiao, S.; Keiser, J.; Chen, M.; Zheng, J.; and Tanner, M.; Current progress in the development and use of artemether for chemoprophylaxis of major human schistosome parasites. Curr. Med. Chem.; 8, 1841-1860 (2001a).
40. Utzinger, J.; Xiao, S.; N'goran, E. K.; Bergquist, R.; and Tanner, M.; The potential of artemether for the control of schistosomiasis. Int. J. Parasitol.; 31, 1549-1562 (2001b).
41. Wolf, S. F.; Temple, P. A.; Kobayashi, M.; Young, D.; Dicig, M.; Lowe, L.; Dzialo, R.; Fitz, L.; Ferenz, C.; Hewick, R. M.; and Et Al. Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. J. Immunol.; 146, 3074-3081 (1991).
42. Wu, G. D.; Zhou, H. J.; and Wu, X. H.; Apoptosis of human umbilical vein endothelial cells induced by artesunate. Vascul. Pharmacol.; 41, 205-212 (2004).
43. Xia, C. Q. and Kao, K. J.; Suppression of interleukin-12 production through endogenously secreted interleukin-10 in activated dendritic cells: involvement of activation of extracellular signal-regulated protein kinase. Scand. J. Immunol.; 58, 23-32 (2003).
44. Yang, Z.; Zhang, X.; Darrah, P. A.; and Mosser, D. M.; The regulation of Th1 responses by the p38 MAPK. J. Immunol.; 185, 6205-6213 (2010).
45. Yap, G.; Pesin, M.; and Sher, A.; Cutting edge: IL-12 is required for the maintenance of IFN-gamma production in T cells mediating chronic resistance to the intracellular pathogen, Toxoplasma gondii. J. Immunol.; 165, 628-631 (2000).
46. Yuzhalin, A. E. and Kutikhin, A. G.; Interleukin-12: clinical usage and molecular markers of cancer susceptibility. Growth Factors, 30, 176-191 (2012).
47. Zhang, L.; Feldman, S. A.; Zheng, Z.; Chinnasamy, N.; Xu, H.; Nahvi, A. V.; Dudley, M. E.; Rosenberg, S. A.; and Morgan, R. A.; Evaluation of γ-retroviral vectors that mediate the inducible expression of IL-12 for clinical application. J. Immunother.; 35, 430-439 (2012).
48. Zhu, C.; Gagnidze, K.; Gemberling, J. H.; and Plevy, S. E.; Characterization of an activation protein-1-binding site in the murine interleukin-12 p40 promoter. Demonstration of novel functional elements by a reductionist approach. J. Biol. Chem.; 276, 18519-18528 (2001).